Menu
Our Story
Who We Are
Latest Updates
← Back to Latest Updates
Press Release
The OPTI-1 trial shows increasing liver-targeted bolus insulin restores liver physiology allowing subjects to decrease Level 2 hypoglycemia by 50% at nighttime
June 2, 2022